OVARIAN NEOPLASMS
Clinical trials for OVARIAN NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new OVARIAN NEOPLASMS trials appear
Sign up with your email to follow new studies for OVARIAN NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo could slow ovarian Cancer's return
Disease control OngoingThis study tests whether adding the immunotherapy drug oregovomab to standard chemotherapy can help people with advanced ovarian cancer live longer without their cancer growing. About 615 newly diagnosed patients who had surgery to remove most of their cancer will receive either …
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE3 • Sponsor: CanariaBio Inc. • Aim: Disease control
Last updated May 17, 2026 00:40 UTC
-
Experimental drug targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-stage study tests an experimental drug called SGN-MesoC2 in 19 adults with advanced solid tumors (like lung, ovarian, or pancreatic cancer) that have not responded to standard treatments. The drug is designed to stick to cancer cells and kill them. The main goals are t…
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 17, 2026 00:32 UTC
-
Ovarian cancer vaccine aims to keep the disease away longer
Disease control OngoingThis study tests a personalized immunotherapy called Vigil in 92 people with advanced ovarian cancer who are currently cancer-free after surgery and chemotherapy. The treatment uses a patient's own tumor cells to train their immune system to fight any remaining cancer cells. The …
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE2 • Sponsor: Gradalis, Inc. • Aim: Disease control
Last updated May 17, 2026 00:31 UTC
-
New drug targets HER2-Positive tumors in four cancer types
Disease control OngoingThis study tests an experimental drug called disitamab vedotin in 120 adults with advanced head/neck, lung, endometrial, or ovarian cancers that have the HER2 marker. The drug is designed to stick to cancer cells and kill them. Participants receive the drug every two weeks to see…
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New pill may delay ovarian cancer return after chemo
Disease control OngoingThis study tests a daily pill called niraparib for people with advanced ovarian cancer who have finished their first round of chemotherapy. The goal is to see if taking niraparib can keep the cancer from growing or coming back longer than a placebo. About 733 participants with st…
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE3 • Sponsor: Tesaro, Inc. • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
New drug cocktail shows promise in slowing advanced ovarian cancer
Disease control OngoingThis phase 3 trial tests whether adding two drugs (dostarlimab and niraparib) to standard chemotherapy can slow the growth of advanced ovarian cancer better than standard treatment alone. About 1,400 women with newly diagnosed stage III or IV ovarian cancer will participate. The …
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE3 • Sponsor: Tesaro, Inc. • Aim: Disease control
Last updated May 04, 2026 16:19 UTC
-
New pill targets Cancer's 'Engine' in first human trial
Disease control OngoingThis is a first-in-human study to test the safety and find the right dose of an experimental pill called ATV-1601. It is for adults with advanced solid tumors, including certain breast, gynecologic, and prostate cancers, that have a specific genetic change called an AKT1 E17K mut…
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Apr 13, 2026 20:17 UTC
-
DNA bank aims to unlock family cancer secrets
Knowledge-focused OngoingThis study collects blood and saliva samples from people with cancer and their family members to build a DNA bank. Researchers will use these samples to study how genes may increase the risk of developing certain cancers. The goal is to better understand inherited cancer tendenci…
Matched conditions: OVARIAN NEOPLASMS
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 00:43 UTC